Bryan Becker

Bryan Becker

Auto-generated profile, based on publicly available information

Bryan Becker

Departments of Medicine, TCU Burnett School of Medicine, Fort Worth, TX

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2000 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Closed access
ROReed A. Omary
Reed A. Omary
JBJ. Greg Baden
J. Greg Baden
BBBryan N. Becker
Bryan N. Becker
JOJon Odorico
Jon Odorico
TGThomas M. Grist
Thomas M. Grist

1 September 2019 in Kidney Medicine
Verified
Journal Article
Open access
JWJohn Wigneswaran
John Wigneswaran
WSWendy StPeter
Wendy StPeter
ANAllen R. Nissenson
Allen R. Nissenson
MKMahesh Krishnan
Mahesh Krishnan
RFRichard Faris
Richard Faris
JLJonathan Lorch
Jonathan Lorch
Patients with end-stage renal disease treated with dialysis are often prescribed complex medication regimens, placing them at risk for drug-drug interactions and other medication-related problems. Particularly in the context of a broader interest in more patient-centered value-based care, improving medication management is an increasingly important focus area. However, current medication management metrics, designed for the broader patient population, may not be well suited to the specific needs of patients with kidney disease, especially given the complexity of medication regimens used by dialysis patients. We propose a kidney pharmacy-focused quality pyramid that is intended to provide a framework to guide dialysis organizations, health care providers, and/or clinicians with respect to an optimal medication management approach for dialysis patients. Incorporation of core programs in medication management, including medication reconciliation, safety programs, and medication therapy management for patients at high risk for medication-related problems, may result in improved outcomes. Although a growing body of evidence supports the concept that active medication management can improve medication adherence and reduce medication-related problems, these strategies are viewed as costly and are not widely deployed. However, if done effectively, pharmacy-led medication management has the potential to be one of the more cost-effective disease management strategies and may greatly improve outcomes for these complex patients.

6 June 2025 in American Journal of Transplantation
Verified
Journal Article
Open access
BBBryan Becker
Bryan Becker
YBYolanda Becker
Yolanda Becker
DADavid Axelrod
David Axelrod
JCJ. Kevin Cmunt
J. Kevin Cmunt
KKKenneth W. Kizer
Kenneth W. Kizer
MSMarty Thomas Sellers
Marty Thomas Sellers
Transplant centers hold the key to accelerating organ use and transplanting more patients more efficiently. However, not all transplant procedures are alike, as organ complexity and patient comorbidities can dramatically increase the risk of the procedures, demanding unique skills and more extensive resources to achieve good outcomes. What if transplant centers could emulate aspects of the trauma center model to ensure that necessary capabilities are consistently applied and uniformly available for all levels of organ risk and patient health? The proposed model recognizes that some transplant centers would have the capacity and aligned resources to care for the most complex patients and different types of organ transplants. Other transplant centers would leverage their available resources for less complex patients and organs. Importantly, this model also provides a template for regular stakeholder review of transplant program performance and episodic certification of transplant center resources. By moving to a tiered trauma center-like certification model, transplant centers, organ allocation policy, and patients could be triaged to the center most capable of providing them timely, effective care.

29 March 2024 in The American Journal of Medicine
Verified
Journal Article
Open access
BBBryan Becker
Bryan Becker
Primary care in the United States is undergoing bursts of evolution in response to health system stresses, changing demographics, and expansion of risk and value-based reimbursement structures. The impact of primary care remains substantive and associated with improved population health. However, the spectrum of services, the nature of the physicians involved and new ways of including the patient in her, or his own care suggests that a new definition of primary care be considered, and patient expectations be heeded and understood. Evolutionary bursts yield new traits and in primary care, they are spawning new care models with significant implications for general internal medicine, internal medicine/pediatrics trained individuals and medicine subspecialties given the focus of these models on Medicare Advantage. Ultimately, changes in reimbursement and creative incentives will be two factors among many that will solidify the next stage of primary care in the (c) 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BYicine (2024) 137:577-581